Loading…
Fraudulent Prescription Prevention Act of 2011
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
84pct
63d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2012 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011 H.R. 1266, Fraudulent Prescription Prevention Act of 2011 H.R. 1925, Prescription Drug Abuse Prevention and Treatment Act of 2011 S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011 S. 882, STOP Act S.968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 S. 1002, Safe Doses Act S. 1612, Targeting Transnational Drug Trafficking Act of 2011
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE
2012 · third_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011 H.R. 1266, Fraudulent Prescription Prevention Act of 2011 H.R. 1925, Prescription Drug Abuse Prevention and Treatment Act of 2011 S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011 S. 882, STOP Act S.968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 S. 1002, Safe Doses Act S. 1612, Targeting Transnational Drug Trafficking Act of 2011
Client expense: $440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE
2012 · second_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011 H.R. 1266, Fraudulent Prescription Prevention Act of 2011 H.R. 1925, Prescription Drug Abuse Prevention and Treatment Act of 2011 S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011 S. 882, STOP Act S.968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 S. 1002, Safe Doses Act S. 1612, Targeting Transnational Drug Trafficking Act of 2011
Client expense: $560,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE
2012 · first_quarter · Law Enforcement/Crime/Criminal Justice
H.R.866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011 H.R.1266, Fraudulent Prescription Prevention Act of 2011 H.R.1925, Prescription Drug Abuse Prevention and Treatment Act of 2011 S.507, Prescription Drug Abuse Prevention and Treatment Act of 2011 S.882, STOP Act S.968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 S.1002, Safe Doses Act S.1612, Targeting Transnational Drug Trafficking Act of 2011
Client expense: $560,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE
2011 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
H.R.866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011 H.R.1266, Fraudulent Prescription Prevention Act of 2011 H.R.1925, Prescription Drug Abuse Prevention and Treatment Act of 2011 S.507, Prescription Drug Abuse Prevention and Treatment Act of 2011 S.882, STOP Act S.968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 S.1002, Safe Doses Act S.1612, Targeting Transnational Drug Trafficking Act of 2011
Client expense: $380,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE
2011 · third_quarter · Health Issues
H.R. 5, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011: Provisions related to FDA and product liability H.R. 1065, Pill Mill Crackdown Act of 2011: Provisions related to prescription drug abuse H.R. 1266, Fraudulent Prescription Prevention Act of 2011: Provisions related to prescription drug abuse H.R. 2182, Generating Antibiotic Incentives Now Act of 2011: Provisions related to antibiotics and incentives H.R. 2119, Ryan Creedon Act of 2011: Provisions related to drug diversion H.R. 2245, Preserving Access to Life-Saving Medications Act of 2011: Provisions related to prescription drug shortages S. 218, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011: Provisions related to FDA and product liability S. 296, Preserving Access to Life-Saving Medications Act: Provisions related to prescription drug shortages S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011: Provisions related to importation S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011: Provisions related to prescription drug abuse S. 2672, Preserving Access to Orphan Drugs Act of 2011: Provisions related to orphan drug definition and health reform fee Health care reform implementation issues, including health reform fee and essential benefits General FDA related advocacy Prescription Drug User Fee Reauthorization Anti-counterfeiting issues Biopharmaceutical innovation policy issues
Client expense: $4,740,000 · Firm income: Not reported
2011 · third_quarter · Law Enforcement/Crime/Criminal Justice
H.R.866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011 H.R.1266, Fraudulent Prescription Prevention Act of 2011 H.R.1925, Prescription Drug Abuse Prevention and Treatment Act of 2011 S.507, Prescription Drug Abuse Prevention and Treatment Act of 2011 S.882, STOP Act S.968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 S.1002, Safe Doses Act S.1612, Targeting Transnational Drug Trafficking Act of 2011
Client expense: $440,000 · Firm income: Not reported
2011 · second_quarter · Health Issues
H.R. 5, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011: Provisions related to FDA and product liability H.R. 1065, Pill Mill Crackdown Act of 2011: Provisions related to prescription drug abuse H.R. 1266, Fraudulent Prescription Prevention Act of 2011: Provisions related to prescription drug abuse H.R. 2182, Generating Antibiotic Incentives Now Act of 2011: Provisions related to antibiotics and incentives H.R. 2119, Ryan Creedon Act of 2011: Provisions related to drug diversion H.R. 2245, Preserving Access to Life-Saving Medications Act of 2011: Provisions related to prescription drug shortages S. 218, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011: Provisions related to FDA and product liability S. 296, Preserving Access to Life-Saving Medications Act: Provisions related to prescription drug shortages S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011: Provisions related to importation S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011: Provisions related to prescription drug abuse Health care reform implementation issues, including health reform fee and essential benefits General FDA advocacy User fee reauthorization Anti-counterfeiting issues Biopharmaceutical innovation policy issues
Client expense: $4,690,000 · Firm income: Not reported
2011 · second_quarter · Law Enforcement/Crime/Criminal Justice
H.R.866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011 H.R.1266, Fraudulent Prescription Prevention Act of 2011 H.R.1925, Prescription Drug Abuse Prevention and Treatment Act of 2011 S.507, Prescription Drug Abuse Prevention and Treatment Act of 2011 S.882, STOP Act S.968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011
Client expense: $580,000 · Firm income: Not reported
2011 · first_quarter · Health Issues
H.R. 1065, Pill Mill Crackdown Act of 2011: prescription drug abuse H.R. 1266, Fraudulent Prescription Prevention Act of 2011: prescription drug abuse S. 218, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011: FDA and product liability issues S. 296, Preserving Access to Life-Saving Medications Act: prescription drug shortages S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011: importation S. 507, Prescription Drug Abuse Prevention and Treatment Act of 2011: prescription drug abuse Health care reform implementation issues including health reform fee and essential benefits General FDA advocacy Biopharmaceutical innovation policy issues
Client expense: $4,540,000 · Firm income: Not reported
2011 · first_quarter · Law Enforcement/Crime/Criminal Justice
H.R.866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011 H.R.1266, Fraudulent Prescription Prevention Act of 2011
Client expense: $660,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE